⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26981421 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4849626 | 0.95 | — | — | |
| SCHEMBL9418098 | 0.76 | — | — | |
| SCHEMBL10395750 | 0.74 | — | — | |
| SCHEMBL7294768 | 0.73 | — | — | |
| SCHEMBL6442843 | 0.70 | — | — | |
| SCHEMBL4397869 | 0.70 | — | — | |
| SCHEMBL438330 | 0.70 | — | — | |
| SCHEMBL5749962 | 0.68 | KDM4E (0.33) | — | |
| SCHEMBL10634539 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2140 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114786734-B | Magnetic tracer composition | 费罗诺娃私人有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-111902148-B | Compositions and methods for treating muscular atrophy and tonic muscular dystrophy | 艾维迪提生物科学公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118267396-A | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118251494-A | Compositions and methods for modulating KRAS expression | 美国微哲默理有限责任公司 | 2024-06-25 | — | — | CN | claimed |
| CN-117751190-A | Compositions and methods for modulating SOS gene expression | 美国微哲默理有限责任公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117222738-A | Compositions and methods for TCR reprogramming using fusion proteins | T细胞受体治疗公司 | 2023-12-12 | — | — | CN | claimed |
| WO-2023217764-A1 | NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME | CALLIDITAS THERAPEUTICS SUISSE SA (CH) | 2023-11-16 | — | — | WO | claimed |
| CN-116916938-A | Muscle targeting complexes and their use for the treatment of facial shoulder humerus muscular dystrophy | 达因疗法公司 | 2023-10-20 | — | — | CN | claimed |
| CN-115666589-A | Compositions and methods for treating facioscapulohumeral muscular dystrophy | 艾维迪提生物科学公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115335062-A | Muscle targeting complexes and their use for modulating genes associated with muscle health | 达因疗法公司 | 2022-11-11 | — | — | CN | claimed |
| EP-0607962-A1 | Photosensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1994-07-27 | — | — | EP | claimed |
| WO-1993009089-A1 | BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-05-13 | — | — | WO | claimed |
| US-4958024-A | REACTION OF CARBAMATE SUBSTITUTED ACRYLIC ESTER, VASODILATORS, HYPOTENSIVE AGENTS | BANYU PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-09-18 | — | — | US | claimed |
| EP-0380019-A2 | Methadone fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1990-08-01 | — | — | EP | claimed |
| US-4914227-A | FOR VASODILATING AND HYPOTENSIVE AGENTS | BANYU PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-04-03 | — | — | US | claimed |
| US-4851028-A | Method of combating undesirable plant growth and of regulating plant growth | CIBA-GEIGY CORPORATION (US) | 1989-07-25 | — | — | US | claimed |
| US-4739106-A | VASODILATION, HYPOTENSIVE AGENTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1988-04-19 | — | — | US | claimed |
| EP-0101023-B1 | PROCESS FOR PREPARING 2-CARBAMOYLOXYALKYL-1,4-DIHYDROPYRIDINE DERIVATIVES AND INTERMEDIATES USEFUL FOR THE PROCESS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1987-07-29 | — | — | EP | claimed |
| EP-0101023-A1 | Process for preparing 2-carbamoyloxyalkyl-1,4-dihydropyridine derivatives and intermediates useful for the process | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1984-02-22 | — | — | EP | claimed |
| EP-0025501-B1 | N-AMINOALKYL INDOLE DERIVATIVES AND THEIR SALTS, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS | Kali-Chemie Pharma GmbH (DE) | 1982-12-29 | — | — | EP | claimed |